XML 51 R41.htm IDEA: XBRL DOCUMENT
v3.20.2

Supplemental Cash Flow Information - Schedule of Supplemental Cash Flow Information (Details) - USD ($) | 9 Months Ended
--- | ---
Sep. 30, 2020 | Sep. 30, 2019
Supplemental Cash Flow Information [Abstract] |  |
Cash paid for interest | $ 101,000 | $ 128,000
Impact of adoption of lease accounting standards |  | 1,616,000
Gain from change in fair value of interest rate swap derivatives |  | 7,000
Common stock issued upon conversion of convertible note |  | 500,000
Equity issued to purchase intangible assets |  | 145,000
Common A Shares issued for marketing services | 210,000 |
Common A Shares issued for Impact BioMedical | 3,132,000 |
Series A Preferred Shares issued for Impact BioMedical | 35,187,000 |
Long-lived assets acquired through settlement of notes receivable | $ 838,000 |

X
- Definition Common A Shares issued for Impact BioMedical. + References No definition available. + Details
Name: | DSS_CommonASharesIssuedForImpactBiomedical
Namespace Prefix: | DSS_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Common A Shares issued for marketing services. + References No definition available. + Details
Name: | DSS_CommonASharesIssuedForMarketingServices
Namespace Prefix: | DSS_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Equity issued to purchase intangible assets. + References No definition available. + Details
Name: | DSS_EquityIssuedToPurchaseIntangibleAssets
Namespace Prefix: | DSS_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Gain from change in fair value of interest rate swap derivatives. + References No definition available. + Details
Name: | DSS_GainLossFromChangeInFairValueOfInterestRateSwapDerivatives
Namespace Prefix: | DSS_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Impact of adoption of lease accounting standards. + References No definition available. + Details
Name: | DSS_ImpactOfAdoptionOfLeaseAccountingStandards
Namespace Prefix: | DSS_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Long-lived assets acquired through settlement of notes receivable. + References No definition available. + Details
Name: | DSS_LonglivedAssetsAcquiredThroughSettlementOfNotesReceivable
Namespace Prefix: | DSS_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Series A Preferred Shares issued for Impact BioMedical. + References No definition available. + Details
Name: | DSS_SeriesAPreferredSharesIssuedForImpactBiomedical
Namespace Prefix: | DSS_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The value of the financial instrument issued [noncash or part noncash] in the conversion of stock. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=121583591&loc=d3e4304-108586 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=121583591&loc=d3e4313-108586 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=121583591&loc=d3e4332-108586 + Details
Name: | us-gaap_ConversionOfStockAmountIssued1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 17 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 25 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585 + Details
Name: | us-gaap_InterestPaidNet
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SupplementalCashFlowInformationAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration